Prospective follow-up of rituximab treatment in 158 patients with refractory autoimmune diseases: Tolerance and safety data from the french registry air (autoimmunity and rituximab)

被引：0

作者：

Gottenberg, J. ^{[1
]}

Combe, B. ^{[2
]}

Dougados, M. ^{[3
]}

Berthelot, J. ^{[4
]}

Hachullas, E. ^{[5
]}

Guillevins, L. ^{[6
]}

Pallot-Prades, B. ^{[7
]}

Costedoat-Chalumeaue, N. ^{[8
]}

DeBandt, M. ^{[9
]}

Sordet, C. ^{[10
]}

Fain, O. ^{[11
]}

Larroche, C. ^{[12
]}

Gaudin, P. ^{[13
]}

Ardizzonne, M. ^{[14
]}

Somogyi, A. ^{[15
]}

Quartier, P. ^{[16
]}

Mariette, X.

机构：

[1] Bicetre Hosp Le Kremlin, Le Kremlin Bicetre, France

[2] Peyronie Hosp, Montpellier, France

[3] Cochin Hosp, Paris, France

[4] Nantes Hosp, Nantes, France

[5] Lille Hosp, Lille, France

[6] Cochin Hosp, Paris, France

[7] St Etienne Hosp, St Etienne, France

[8] La Pitie Salpetriere Hosp, Paris, France

[9] Robert Ballanger Hosp, Aulnay Sous Bois, France

[10] Strasbourg Hosp, Strasbourg, France

[11] Internal Med Jean Verdier Hosp, Bondy, France

[12] Avicenne Hosp, Bobigny, France

[13] Grenoble Hosp, Grenoble, France

[14] Mulhouse Hosp, Mulhouse, France

[15] St Germain Laye Hosp, St Gernmain En Laye, France

[16] Hop Necker Enfants Malad, Paris, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：431 / 431

页数：1

共 50 条

[31] Duration of response to a single treatment course of rituximab (RTX) in active rheumatoid arthritis (RA): Efficacy and safety data from a 2-year follow-up of a randomised trial [J].

Sheeran, T ;

Emery, P ;

Lehane, PB ;

Saiedabadi, N ;

Shaw, TM .

RHEUMATOLOGY, 2005, 44 :I2-I2

[32] Antithrombotic treatment in patients with stable CAD and AF-5-year follow-up data from the CLARIFY registry [J].

Wakilil, R. ;

Rizas, K. ;

Greenlaw, N. ;

Steg, P. G. ;

Kaeaeb, S. .

EUROPEAN HEART JOURNAL, 2017, 38 :611-611

[33] Magrolimab in Combination With Rituximab in Patients With Relapsed or Refractory Indolent Non-Hodgkin Lymphoma: 3-Year Follow-up Results From a Phase 1/2 Trial [J].

Amitkumar, Mehta ;

Leslie, Popplewell ;

Collins, Graham P. ;

Sonali, Smith ;

Ian, Flinn ;

Bartlett, Nancy S. ;

Nilanjan, Ghosh ;

Carolc, O'Hear ;

Yanan, Huo ;

Bertha, Villa ;

Indu, Lal ;

Ranjana, Advani ;

Mark, Roschewski .

AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 :S21-S21

[34] Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry [J].

Oddone, Francesco ;

Roberti, Gloria ;

Giammaria, Sara ;

Posarelli, Chiara ;

Ghirelli, Giorgio ;

Mastropasqua, Leonardo ;

Agnifili, Luca ;

Micelli Ferrari, Tommaso ;

Pace, Vincenzo ;

Nucci, Paolo ;

Sacchi, Matteo ;

Monsellato, Gianluca ;

Altafini, Romeo ;

Scuderi, Gianluca ;

Perdicchi, Andrea ;

Uva, Maurizio ;

Carnevale, Carmela ;

Covello, Giuseppe ;

Maglionico, Maria Novella ;

Fea, Antonio ;

Figus, Michele .

EYE, 2024, 38 (01) :103-111

[35] Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry [J].

Francesco Oddone ;

Gloria Roberti ;

Sara Giammaria ;

Chiara Posarelli ;

Giorgio Ghirelli ;

Leonardo Mastropasqua ;

Luca Agnifili ;

Tommaso Micelli Ferrari ;

Vincenzo Pace ;

Paolo Nucci ;

Matteo Sacchi ;

Gianluca Monsellato ;

Romeo Altafini ;

Gianluca Scuderi ;

Andrea Perdicchi ;

Maurizio Uva ;

Carmela Carnevale ;

Giuseppe Covello ;

Maria Novella Maglionico ;

Antonio Fea ;

Michele Figus .

Eye, 2024, 38 :103-111

[36] Long-Term Follow-up of Bendamustine Plus Rituximab Regimen in 69 Treatment Naive (TN) Patients with Waldenstrom Macroglobulinemia, a Study on Behalf of the French Innovative Leukemia Organization (FILO) [J].

Laribi, Kamel ;

Poulain, Stephanie ;

Willems, Lise ;

Merabet, Fatiha ;

Herbaux, Charles ;

Weil, Damien Roos ;

de Materre, Alix Baugier ;

Roussel, Xavier ;

Tricot, Sabine ;

Dupuis, Jehan ;

Le Calloch, Ronan ;

Bareau, Benoit ;

Bene, Marie C. ;

Leblond, Veronique .

BLOOD, 2022, 140 :3627-3628

[37] Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNF alpha drugs: results from the observational retrospective-prospective RUBINO study [J].

Bazzichi, L. ;

Biasi, D. ;

Tinazzi, E. ;

Muratore, M. ;

Pellerito, R. ;

Russo, R. ;

Santi, M. Corsaro ;

De Sandre, P. ;

Epis, O. ;

Granata, M. ;

Kroegler, B. ;

Meschini, C. ;

Versace, F. ;

Astolfi, C. .

REUMATISMO, 2014, 66 (03) :224-232

[38] Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients [J].

Eva González-Barca ;

Francisco Javier Capote ;

Jose Gómez-Codina ;

Carlos Panizo ;

Antonio Salar ;

Juan-Manuel Sancho ;

Andres López ;

Javier Briones ;

Andres Muñoz ;

Maite Encuentra ;

Santiago Mercadal ;

Eva Domingo-Domenech ;

Alberto Fernández de Sevilla .

Annals of Hematology, 2021, 100 :1023-1029

[39] Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients [J].

Gonzalez-Barca, Eva ;

Capote, Francisco Javier ;

Gomez-Codina, Jose ;

Panizo, Carlos ;

Salar, Antonio ;

Sancho, Juan-Manuel ;

Lopez, Andres ;

Briones, Javier ;

Munoz, Andres ;

Encuentra, Maite ;

Mercadal, Santiago ;

Domingo-Domenech, Eva ;

de Sevilla, Alberto Fernandez .

ANNALS OF HEMATOLOGY, 2021, 100 (04) :1023-1029

[40] TAFAMIDIS FOR THE TREATMENT OF FAMILIAL AMYLOID POLYNEUROPATHY: EFFICACY AND SAFETY DATA FROM A GROUP OF PORTUGUESE PATIENTS WITH THREE YEARS FOLLOW-UP [J].

Coelho, T. ;

Rodrigues, C. ;

Fonseca, I .

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) :245-245

← 1 2 3 4 5 →